 | • レポートコード：GIR201115343 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ワクチン技術の世界市場を調査対象にし、ワクチン技術の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（感染症、アレルギー、癌）、用途別分析（人間用、動物用）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott、GE Healthcare、Pfizer、Thermo Fisher Scientific、Bayer、Johnson and Johnson、Glaxosmithkline ・企業別売上、市場シェア ・ワクチン技術の地域別市場分析 ・ワクチン技術の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ワクチン技術のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ワクチン技術のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ワクチン技術の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ワクチン技術の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ワクチン技術の種類別市場規模2015-2020：感染症、アレルギー、癌 ・ワクチン技術の用途別市場規模2015-2020：人間用、動物用 ・ワクチン技術の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Vaccine Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Vaccine Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Vaccine Technologies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vaccine Technologies market has been segmented into:
Infection
Allergy
Cancer
By Application, Vaccine Technologies has been segmented into:
Humans
Animals
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine Technologies market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine Technologies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine Technologies market.
The report offers in-depth assessment of the growth and other aspects of the Vaccine Technologies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Vaccine Technologies Market Share Analysis
Vaccine Technologies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine Technologies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine Technologies sales, revenue and market share for each player covered in this report.
The major players covered in Vaccine Technologies are:
Abbott
GE Healthcare
Pfizer
Thermo Fisher Scientific
Bayer
Johnson and Johnson
Glaxosmithkline
1 Vaccine Technologies Market Overview
1.1 Product Overview and Scope of Vaccine Technologies
1.2 Classification of Vaccine Technologies by Type
1.2.1 Global Vaccine Technologies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Vaccine Technologies Revenue Market Share by Type in 2019
1.2.3 Infection
1.2.4 Allergy
1.2.5 Cancer
1.3 Global Vaccine Technologies Market by Application
1.3.1 Overview: Global Vaccine Technologies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Humans
1.3.3 Animals
1.4 Global Vaccine Technologies Market by Regions
1.4.1 Global Vaccine Technologies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Vaccine Technologies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Vaccine Technologies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Vaccine Technologies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Vaccine Technologies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Vaccine Technologies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Vaccine Technologies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GE Healthcare SWOT Analysis
2.2.4 GE Healthcare Product and Services
2.2.5 GE Healthcare Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer SWOT Analysis
2.5.4 Bayer Product and Services
2.5.5 Bayer Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson and Johnson
2.6.1 Johnson and Johnson Details
2.6.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson and Johnson SWOT Analysis
2.6.4 Johnson and Johnson Product and Services
2.6.5 Johnson and Johnson Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
2.7 Glaxosmithkline
2.7.1 Glaxosmithkline Details
2.7.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Glaxosmithkline SWOT Analysis
2.7.4 Glaxosmithkline Product and Services
2.7.5 Glaxosmithkline Vaccine Technologies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Vaccine Technologies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Vaccine Technologies Players Market Share
3.2.2 Top 10 Vaccine Technologies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Vaccine Technologies Revenue and Market Share by Regions
4.2 North America Vaccine Technologies Revenue and Growth Rate (2015-2020)
4.3 Europe Vaccine Technologies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine Technologies Revenue and Growth Rate (2015-2020)
4.5 South America Vaccine Technologies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Vaccine Technologies Revenue and Growth Rate (2015-2020)
5 North America Vaccine Technologies Revenue by Countries
5.1 North America Vaccine Technologies Revenue by Countries (2015-2020)
5.2 USA Vaccine Technologies Revenue and Growth Rate (2015-2020)
5.3 Canada Vaccine Technologies Revenue and Growth Rate (2015-2020)
5.4 Mexico Vaccine Technologies Revenue and Growth Rate (2015-2020)
6 Europe Vaccine Technologies Revenue by Countries
6.1 Europe Vaccine Technologies Revenue by Countries (2015-2020)
6.2 Germany Vaccine Technologies Revenue and Growth Rate (2015-2020)
6.3 UK Vaccine Technologies Revenue and Growth Rate (2015-2020)
6.4 France Vaccine Technologies Revenue and Growth Rate (2015-2020)
6.5 Russia Vaccine Technologies Revenue and Growth Rate (2015-2020)
6.6 Italy Vaccine Technologies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Vaccine Technologies Revenue by Countries
7.1 Asia-Pacific Vaccine Technologies Revenue by Countries (2015-2020)
7.2 China Vaccine Technologies Revenue and Growth Rate (2015-2020)
7.3 Japan Vaccine Technologies Revenue and Growth Rate (2015-2020)
7.4 Korea Vaccine Technologies Revenue and Growth Rate (2015-2020)
7.5 India Vaccine Technologies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine Technologies Revenue and Growth Rate (2015-2020)
8 South America Vaccine Technologies Revenue by Countries
8.1 South America Vaccine Technologies Revenue by Countries (2015-2020)
8.2 Brazil Vaccine Technologies Revenue and Growth Rate (2015-2020)
8.3 Argentina Vaccine Technologies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Vaccine Technologies by Countries
9.1 Middle East & Africa Vaccine Technologies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Vaccine Technologies Revenue and Growth Rate (2015-2020)
9.3 UAE Vaccine Technologies Revenue and Growth Rate (2015-2020)
9.4 Egypt Vaccine Technologies Revenue and Growth Rate (2015-2020)
9.5 South Africa Vaccine Technologies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Vaccine Technologies Revenue and Market Share by Type (2015-2020)
10.2 Global Vaccine Technologies Market Forecast by Type (2019-2024)
10.3 Infection Revenue Growth Rate (2015-2025)
10.4 Allergy Revenue Growth Rate (2015-2025)
10.5 Cancer Revenue Growth Rate (2015-2025)
11 Global Vaccine Technologies Market Segment by Application
11.1 Global Vaccine Technologies Revenue Market Share by Application (2015-2020)
11.2 Vaccine Technologies Market Forecast by Application (2019-2024)
11.3 Humans Revenue Growth (2015-2020)
11.4 Animals Revenue Growth (2015-2020)
12 Global Vaccine Technologies Market Size Forecast (2021-2025)
12.1 Global Vaccine Technologies Market Size Forecast (2021-2025)
12.2 Global Vaccine Technologies Market Forecast by Regions (2021-2025)
12.3 North America Vaccine Technologies Revenue Market Forecast (2021-2025)
12.4 Europe Vaccine Technologies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Vaccine Technologies Revenue Market Forecast (2021-2025)
12.6 South America Vaccine Technologies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Vaccine Technologies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Vaccine Technologies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine Technologies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Vaccine Technologies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Vaccine Technologies Major Business
Table 7. Abbott Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Vaccine Technologies Product and Solutions
Table 10. Abbott Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GE Healthcare Corporate Information, Location and Competitors
Table 12. GE Healthcare Vaccine Technologies Major Business
Table 13. GE Healthcare Vaccine Technologies Total Revenue (USD Million) (2018-2019)
Table 14. GE Healthcare SWOT Analysis
Table 15. GE Healthcare Vaccine Technologies Product and Solutions
Table 16. GE Healthcare Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Vaccine Technologies Major Business
Table 19. Pfizer Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Vaccine Technologies Product and Solutions
Table 22. Pfizer Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Vaccine Technologies Major Business
Table 25. Thermo Fisher Scientific Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Vaccine Technologies Product and Solutions
Table 28. Thermo Fisher Scientific Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Bayer Corporate Information, Location and Competitors
Table 30. Bayer Vaccine Technologies Major Business
Table 31. Bayer Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 32. Bayer SWOT Analysis
Table 33. Bayer Vaccine Technologies Product and Solutions
Table 34. Bayer Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson and Johnson Corporate Information, Location and Competitors
Table 36. Johnson and Johnson Vaccine Technologies Major Business
Table 37. Johnson and Johnson Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 38. Johnson and Johnson SWOT Analysis
Table 39. Johnson and Johnson Vaccine Technologies Product and Solutions
Table 40. Johnson and Johnson Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Glaxosmithkline Corporate Information, Location and Competitors
Table 42. Glaxosmithkline Vaccine Technologies Major Business
Table 43. Glaxosmithkline Vaccine Technologies Total Revenue (USD Million) (2017-2018)
Table 44. Glaxosmithkline SWOT Analysis
Table 45. Glaxosmithkline Vaccine Technologies Product and Solutions
Table 46. Glaxosmithkline Vaccine Technologies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Vaccine Technologies Revenue (Million USD) by Players (2015-2020)
Table 48. Global Vaccine Technologies Revenue Share by Players (2015-2020)
Table 49. Global Vaccine Technologies Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Vaccine Technologies Revenue Market Share by Regions (2015-2020)
Table 51. North America Vaccine Technologies Revenue by Countries (2015-2020)
Table 52. North America Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Table 53. Europe Vaccine Technologies Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Vaccine Technologies Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Vaccine Technologies Revenue by Countries (2015-2020)
Table 56. South America Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Vaccine Technologies Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Table 59. Global Vaccine Technologies Revenue (Million USD) by Type (2015-2020)
Table 60. Global Vaccine Technologies Revenue Share by Type (2015-2020)
Table 61. Global Vaccine Technologies Revenue Forecast by Type (2021-2025)
Table 62. Global Vaccine Technologies Revenue by Application (2015-2020)
Table 63. Global Vaccine Technologies Revenue Share by Application (2015-2020)
Table 64. Global Vaccine Technologies Revenue Forecast by Application (2021-2025)
Table 65. Global Vaccine Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Vaccine Technologies Picture
Figure 2. Global Vaccine Technologies Revenue Market Share by Type in 2019
Figure 3. Infection Picture
Figure 4. Allergy Picture
Figure 5. Cancer Picture
Figure 6. Vaccine Technologies Revenue Market Share by Application in 2019
Figure 7. Humans Picture
Figure 8. Animals Picture
Figure 9. Global Vaccine Technologies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Vaccine Technologies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Vaccine Technologies Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Vaccine Technologies Revenue Market Share in 2019
Figure 18. Global Top 10 Players Vaccine Technologies Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Vaccine Technologies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Vaccine Technologies Revenue Market Share by Regions (2015-2020)
Figure 22. Global Vaccine Technologies Revenue Market Share by Regions in 2018
Figure 23. North America Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 24. Europe Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 26. South America Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 28. North America Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Figure 29. North America Vaccine Technologies Revenue Market Share by Countries in 2019
Figure 30. USA Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 31. Canada Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 33. Europe Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Vaccine Technologies Revenue Market Share by Countries in 2019
Figure 35. Germany Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 36. UK Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 37. France Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 38. Russia Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 39. Italy Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Vaccine Technologies Revenue Market Share by Countries in 2019
Figure 42. China Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 43. Japan Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 44. Korea Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 45. India Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 47. South America Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Figure 48. South America Vaccine Technologies Revenue Market Share by Countries in 2019
Figure 49. Brazil Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Vaccine Technologies Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Vaccine Technologies Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 54. UAE Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Vaccine Technologies Revenue and Growth Rate (2015-2020)
Figure 57. Global Vaccine Technologies Revenue Share by Type (2015-2020)
Figure 58. Global Vaccine Technologies Revenue Share by Type in 2019
Figure 59. Global Vaccine Technologies Market Share Forecast by Type (2021-2025)
Figure 60. Global Infection Revenue Growth Rate (2015-2020)
Figure 61. Global Allergy Revenue Growth Rate (2015-2020)
Figure 62. Global Cancer Revenue Growth Rate (2015-2020)
Figure 63. Global Vaccine Technologies Revenue Share by Application (2015-2020)
Figure 64. Global Vaccine Technologies Revenue Share by Application in 2019
Figure 65. Global Vaccine Technologies Market Share Forecast by Application (2021-2025)
Figure 66. Global Humans Revenue Growth Rate (2015-2020)
Figure 67. Global Animals Revenue Growth Rate (2015-2020)
Figure 68. Global Vaccine Technologies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Vaccine Technologies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Vaccine Technologies Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Vaccine Technologies Revenue Market Forecast (2021-2025)
Figure 72. Europe Vaccine Technologies Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Vaccine Technologies Revenue Market Forecast (2021-2025)
Figure 74. South America Vaccine Technologies Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Vaccine Technologies Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
鼻インフルエンザワクチンの世界市場 2020年 Market Overview The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…- 点鼻薬ワクチンの世界市場 2020年 Market Overview The Nasal Spray Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 肺炎球菌ワクチンの世界市場 2020年 Market Overview The Pneumococcal Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 髄膜炎菌感染症ワクチンの世界市場 2020年 Market Overview The global Meningococcal Infections Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meningococca…
- 23価肺炎球菌多糖ワクチンの世界市場 2020年 Market Overview The 23-Valent Pneumococcal Polysaccharide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…